MELINTA THERAPEUTICS, INC. Contracts & Agreements
120 Contracts & Agreements
- Business Finance (39 contracts)
- Business Formation (2)
- Business Operations (14)
- Human Resources (36)
- Intellectual Property (10)
- Real Estate (1)
- Uncategorized (18)
- Restructuring Support Agreement, dated December 27, 2019, by and between the Debtors and the Supporting Lenders (Filed With SEC on December 27, 2019)
- Separation and Release Agreement, dated August 29, 2019, between Melinta Therapeutics, Inc. and John H. Johnson (Filed With SEC on September 3, 2019)
- First Amendment, dated as of June 28, 2019, by and among Melinta Therapeutics, Inc., the other Loan Parties thereto, Vatera Healthcare Partners LLC and Oikos Investment Partners... (Filed With SEC on July 1, 2019)
- Employment Agreement, dated February 22, 2019, between Melinta Therapeutics, Inc. and John H. Johnson (Filed With SEC on February 25, 2019)
- Second Amended and Restated Senior Subordinated Convertible Loan Agreement, originally dated as of December 31, 2018, and amended and restated as of January 14, 2019, and February... (Filed With SEC on February 25, 2019)
- First Amendment to Facility Agreement, dated as of January 14, 2019, by and among Melinta Therapeutics, Inc., Deerfield Special Situations Fund, L.P., Deerfield Private Design... (Filed With SEC on January 16, 2019)
- Amended and Restated Senior Subordinated Convertible Loan Agreement, originally dated as of December 31, 2018, and amended and restated as of January 14, 2019, by and among... (Filed With SEC on January 16, 2019)
- Senior Subordinated Convertible Loan Agreement, dated as of December 31, 2018, by and among Melinta Therapeutics, Inc., Vatera Healthcare Partners LLC and Vatera Investment... (Filed With SEC on January 3, 2019)
- Debt Commitment Letter, dated December 18, 2018, by and among Melinta Therapeutics, Inc., Vatera Healthcare Partners LLC and Vatera Investment Partners LLC (Filed With SEC on December 19, 2018)
- Purchase Agreement, dated November 19, 2018, by and between Melinta Therapeutics, Inc. and Vatera Healthcare Partners, LLC (Filed With SEC on November 19, 2018)
- Employment Inducement Stock Option Agreement with Peter J. Milligan (Filed With SEC on November 7, 2018)
- Employment Agreement with Peter J. Milligan dated September 17, 2018 (Filed With SEC on November 7, 2018)
- Change in Control and Severance Agreement with Peter J. Milligan dated September 17, 2018 (Filed With SEC on November 7, 2018)
- License Agreement, dated September 28, 2018, between the Company and A. Menarini Industrie Farmaceutiche Riunite S.r.l (Filed With SEC on November 7, 2018)
- Amendment No. 2 to Exclusive License and Development Agreement, dated as of May 8, 2013, and amended as of September 26, 2013, by and between Cempra Pharmaceuticals, inc. and... (Filed With SEC on November 7, 2018)
- Commitment Letter, dated November 6, 2018, by and between Melinta Therapeutics, Inc. and Vatera Healthcare Partners LLC (Filed With SEC on November 7, 2018)
- Employment Agreement, dated October 22, 2018, between Melinta Therapeutics, Inc. and John H. Johnson (Filed With SEC on October 24, 2018)
- Side Letter Agreement with Daniel Mark Wechsler, dated October 23, 2018 (Filed With SEC on October 24, 2018)
- Separation and Release Agreement between Melinta Therapeutics, Inc. and Paul Estrem, delivered on September 17, 2018 (Filed With SEC on October 5, 2018)
- Amendment No. 1 to D. Wechsler Employment Agreement, dated May 17, 2018 (Filed With SEC on August 9, 2018)
- Form of Option Agreement (Filed With SEC on June 14, 2018)
- Form of Option Agreement (Filed With SEC on June 14, 2018)
- Amended and Restated License Agreement, dated May 1, 2017, between Melinta Therapeutics, Inc. and Wakunaga Pharmaceutical Co. Ltd (Filed With SEC on June 8, 2018)
- License and Supply Agreement, dated November 30, 2010, by and between Melinta Therapeutics, Inc. and Cydex Pharmaceuticals, Inc. (a wholly owned subsidiary of Ligand... (Filed With SEC on June 8, 2018)
- Underwriting Agreement, dated May 23, 2018 (Filed With SEC on May 29, 2018)
- Warrant Agreement, dated December 17, 2014, by and between Melinta Therapeutics, Inc. and Hercules Technology Growth Capital, Inc (Filed With SEC on March 14, 2018)
- Amendment No. 1 to the Cempra, Inc. 2011 Equity Incentive Plan, as amended March 9, 2018 (Filed With SEC on March 14, 2018)
- Letter Agreement, dated November 8, 2013, as amended, by and between Melinta Therapeutics, Inc. and Paul Estrem, as amended and restated on March 16, 2015 (Filed With SEC on March 14, 2018)
- Amended and Restated Severance Agreement, dated August 29, 2017, by and between Melinta Therapeutics, Inc. and Paul Estrem (Filed With SEC on March 14, 2018)
- Employee Noncompetition, Nondisclosure and Developments Agreement, dated December 9, 2013, by and between Melinta Therapeutics, Inc. and Paul Estrem (Filed With SEC on March 14, 2018)
- Letter Agreement, dated November 18, 2013, by and between Melinta Therapeutics, Inc. and Sue Cammarata (Filed With SEC on March 14, 2018)
- Amended and Restated Severance Agreement, dated August 29, 2017, by and between Melinta Therapeutics, Inc. and Sue Cammarata (Filed With SEC on March 14, 2018)
- Employee Noncompetition, Nondisclosure and Developments Agreement, dated November 18, 2013, by and between Melinta Therapeutics, Inc. and Sue Cammarata (Filed With SEC on March 14, 2018)
- Letter Agreement, dated as of December 2, 2001, by and between Melinta Therapeutics, Inc. and Erin Duffy (Filed With SEC on March 14, 2018)
- Amended and Restated Severance Agreement, dated August 29, 2017, by and between Melinta Therapeutics, Inc. and Erin Duffy (Filed With SEC on March 14, 2018)
- Employee Noncompetition, Nondisclosure and Developments Agreement, dated January 9, 2001, by and between Melinta Therapeutics, Inc. and Erin Duffy (Filed With SEC on March 14, 2018)
- Letter Agreement, dated as of February 5, 2016, by and between Melinta Therapeutics, Inc. and John Temperato (Filed With SEC on March 14, 2018)
- Employee Noncompetition, Nondisclosure and Developments Agreement, dated as of February 16, 2016, by and between Melinta Therapeutics, Inc. and John Temperato (Filed With SEC on March 14, 2018)
- Amended and Restated Severance Agreement, dated August 29, 2017, by and between Melinta Therapeutics, Inc. and John Temperato (Filed With SEC on March 14, 2018)
- Amended and Restated License Agreement, dated May 1, 2017, between Melinta Therapeutics, Inc. and Wakunaga Pharmaceutical Co. Ltd (Filed With SEC on March 14, 2018)
- Patheon Master Manufacturing Services Agreement, dated July 20, 2016, by and between Melinta Therapeutics, Inc. and Patheon UK Limited (Filed With SEC on March 14, 2018)
- Separation and Release Agreement, dated December 21, 2017, between Melinta Therapeutics, Inc. and John Temperato (Filed With SEC on March 14, 2018)
- Amendment to the License Agreement, dated as of January 6, 2009, by and between Eli Lilly and Company and Targanta Therapeutics Corporation (Filed With SEC on March 14, 2018)
- Facility Agreement, dated as of January 5, 2018, by and among Melinta Therapeutics, Inc., the other loan parties thereto, and Cortland Capital Market Services LLC, as Agent (Filed With SEC on January 10, 2018)
- Registration Rights Agreement, dated as of January 5, 2018, between Melinta Therapeutics, Inc. and The Medicines Company (Filed With SEC on January 9, 2018)
- Registration Rights Agreement, dated as of January 5, 2018, between Melinta Therapeutics, Inc. and Deerfield Private Design Fund IV, L.P., Deerfield Private Design Fund III, L.P.,... (Filed With SEC on January 9, 2018)
- Warrant W-1 to purchase shares of common Stock issued to Deerfield Private Design Fund IV, L.P., dated January 5, 2018 (Filed With SEC on January 9, 2018)
- Warrant W-2 to purchase shares of common Stock issued to Deerfield Private Design Fund III, L.P., dated January 5, 2018 (Filed With SEC on January 9, 2018)
- Warrant W-3 to purchase shares of common Stock issued to Deerfield Special Situations Fund, L.P., dated January 5, 2018 (Filed With SEC on January 9, 2018)
- Securities Purchase Agreement, dated January 5, 2018, between Melinta Therapeutics, Inc. and Deerfield Private Design Fund IV, L.P., Deerfield Private Design Fund III, L.P., and... (Filed With SEC on January 9, 2018)
- Facility Agreement, dated as of January 5, 2018, by and among Melinta Therapeutics, Inc., the other loan parties thereto, and Cortland Capital Market Services LLC, as Agent (Filed With SEC on January 9, 2018)
- Royalty Agreement, dated January 5, 2018, between Melinta Therapeutics, Inc. and Deerfield Private Design Fund IV, L.P., Deerfield Private Design Fund III, L.P., and Deerfield... (Filed With SEC on January 9, 2018)
- Purchase and Sale Agreement, dated as of November 28, 2017, by and between The Medicines Company and Melinta Therapeutics, Inc (Filed With SEC on December 1, 2017)
- Voting Agreement, dated as of November 28, 2017, by and between The Medicines Company, Vatera Healthcare Partners LLC, LUPA GmbH, JWC Rib-X LLC, Malin Life Sciences Holdings... (Filed With SEC on December 1, 2017)
- Voting Agreement, dated as of November 28, 2017, by and between The Medicines Company, Warburg Pincus Netherlands Private Equity VIII C.V. I, WP-WPVIII Investors, L.P. and Warburg... (Filed With SEC on December 1, 2017)
- Letter, dated November 28, 2017, by and between Vatera Healthcare Partners LLC and Melinta Therapeutics, Inc (Filed With SEC on December 1, 2017)
- Letter, dated November 28, 2017, by and between JWC Rib-X LLC and Melinta Therapeutics, Inc (Filed With SEC on December 1, 2017)
- Letter, dated November 28, 2017, by and between Deerfield Private Design Fund IV, L.P. and Melinta Therapeutics, Inc (Filed With SEC on December 1, 2017)
- Registration Rights Agreement, dated as of November 3, 2017, among Cempra and the Melinta stockholders thereto (Filed With SEC on November 3, 2017)
- Form of Individual Director Indemnification Agreements (Filed With SEC on November 3, 2017)
- Form of Continuing Individual Director Indemnification Agreements (Filed With SEC on November 3, 2017)
- Form of Fund Director Indemnification Agreements (Filed With SEC on November 3, 2017)
- Employment Agreement, dated October 30, 2017, between Melinta Therapeutics, Inc. and Dan Wechsler (Filed With SEC on November 3, 2017)
- CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on June 28, 2017)
- AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on June 28, 2017)
- CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on February 28, 2017)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 28, 2017)
- RETIREMENT AND CONSULTING AGREEMENT (Filed With SEC on February 28, 2017)
- CEMPRA, INC. $150,000,000 SALESAGREEMENT (Filed With SEC on May 6, 2016)
- Option and License Agreement (Filed With SEC on February 25, 2016)
- API MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on February 25, 2016)
- 4,166,667 Shares CEMPRA, INC. COMMONSTOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on January 7, 2016)
- CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on October 19, 2015)
- FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 19, 2015)
- FIRST AMENDMENT TO CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on October 19, 2015)
- FIRST AMENDMENT TO CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on October 19, 2015)
- FIRST AMENDMENT TO CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on October 19, 2015)
- CEMPRA, INC. CEMPRAPHARMACEUTICALS, INC. CEM-102 PHARMACEUTICALS, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on July 16, 2015)
- CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on April 30, 2015)
- 5,250,000 Shares CEMPRA, INC. COMMONSTOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on January 8, 2015)
- AMENDMENT NO. 2 TO SALES AGREEMENT (Filed With SEC on October 17, 2014)
- CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on May 29, 2014)
- AMENDMENT NO. 3 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on April 2, 2014)
- DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on October 29, 2013)
- AMENDMENT NO. 1 TO EXCLUSIVE LICENSE AND DEVELOPMENT AGREEMENT (Filed With SEC on October 29, 2013)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 13, 2013)
- CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on August 13, 2013)
- CEMPRA, INC. 2011 EQUITY INCENTIVE PLAN Approved by the Board: October 11, 2011 Approved by the Stockholders: February 2, 2012 Amended by theStockholders (Section 3(a)): May 23,... (Filed With SEC on July 31, 2013)
- EXCLUSIVE LICENSE AND DEVELOPMENT AGREEMENT (Filed With SEC on July 31, 2013)
- SUPPLY AGREEMENT (Filed With SEC on July 31, 2013)
- 7,250,000 Shares Cempra, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 14, 2013)
- WARRANT AGREEMENT To Purchase Shares of Common Stock of Cempra, Inc. Dated as of May 31, 2013 (the Effective Date) (Filed With SEC on June 6, 2013)
- AMENDED AND RESTATED WARRANT AGREEMENT To Purchase Shares of the Common Stock of Cempra, Inc. Dated as of December 20, 2011 (the EffectiveDate) Amended and Restated on May 31,... (Filed With SEC on June 6, 2013)
- AMENDMENT NO. 2 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on June 6, 2013)
- API MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on March 7, 2013)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 24, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 24, 2012)
- Portions of this exhibit marked [*] are requested to be treated confidentially. (Filed With SEC on August 8, 2012)
- FIFTH AMENDMENT TO CEMPRA HOLDINGS, LLC SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT (Filed With SEC on January 30, 2012)
- FIFTH AMENDMENT TO CEMPRA HOLDINGS, LLC SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT (Filed With SEC on January 13, 2012)
- CEMPRA, INC. SIXTH AMENDED AND RESTATED 2006 STOCK PLAN (Filed With SEC on January 13, 2012)
- CEMPRA, INC. 2011 EQUITY INCENTIVE PLAN Approved by the Board: October 11, 2011 Approved by the Stockholders: , 2012 Termination Date: October 11, 2021 (Filed With SEC on January 13, 2012)
- [Number of Firm Shares] Shares CEMPRA, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on December 22, 2011)
- CEMPRA, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE CUSIP NUMBER 15130J 109 (Filed With SEC on December 22, 2011)
- WARRANT AGREEMENT To Purchase Shares of the Preferred Class C Shares of Cempra Holdings, LLC Dated as of December 20, 2011 (the Effective Date) (Filed With SEC on December 22, 2011)
- SECURED TERM LOAN A PROMISSORY NOTE (Filed With SEC on December 22, 2011)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on December 22, 2011)
- SECOND GLOBAL AMENDMENT TO UNSECURED CONVERTIBLE PROMISSORY NOTES Issued August 5, 2011 (Filed With SEC on December 22, 2011)
- CEMPRA, INC. SIXTH AMENDED AND RESTATED 2006 STOCK PLAN (Filed With SEC on November 22, 2011)
- CEMPRA, INC. 2011 EQUITY INCENTIVE PLAN Approved by the Board: October 11, 2011 Approved by the Stockholders: , 2011 Termination Date: , 2021 (Filed With SEC on November 22, 2011)
- OFFICE LEASE AGREEMENT between PROPERTY RESERVE, INC. as Landlord and CEMPRA PHARMACEUTICALS, INC., as Tenant [Quadrangle IV] TABLE OF CONTENTS (Filed With SEC on November 22, 2011)
- CEMPRA HOLDINGS, LLC PLAN OF CONVERSION (Filed With SEC on October 12, 2011)
- CEMPRA, INC. REGISTRATIONRIGHTS AGREEMENT [ ], 2011 CEMPRA, INC. REGISTRATION RIGHTS AGREEMENT TABLE OFCONTENTS (Filed With SEC on October 12, 2011)
- CEMPRA HOLDINGS, LLC PREFERRED UNIT PURCHASE WARRANT Void After August , 2018 (Filed With SEC on October 12, 2011)
- CEMPRA HOLDINGS, LLC UNSECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 12, 2011)
- INDEMNIFICATION AGREEMENT (Filed With SEC on October 12, 2011)
- CEMPRA, INC. SIXTH AMENDED AND RESTATED 2006 STOCK PLAN (Filed With SEC on October 12, 2011)
- CEMPRA, INC. 2011 EQUITY INCENTIVE PLAN Approved by the Board: October 11, 2011 Approved by the Stockholders: , 2011 Termination Date: , 2021 (Filed With SEC on October 12, 2011)
- Portions of this exhibit marked [*] are requested to be treated confidentially. COLLABORATIVE RESEARCH AND DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on October 12, 2011)
- Portions of this exhibit marked [*] are requested to be treated confidentially. SUPPLY AGREEMENT (Filed With SEC on October 12, 2011)